Camden Partners, founded in 1995, provides seed and growth capital. Seed strategy leverages sponsored research and IP ownership, growing commercially viable technologies by filling the gap between public research funding and Series A financing. Grow...Show all
Phone: 410-878-6809
500 East Pratt Street
Suite 1200
Baltimore, 21202
Maryland, United States
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-09-21 | Volly | Series B | $11M | New Capital Partners |
2020-09-15 | eFileCabinet | Series C | $11.5M | AllegisCyber Capital, AllegisNL, Oquirrh Ventures, and Signal Peak Ventures |
2020-07-29 | Perfuse Therapeutics | Series A | $9M | Hatteras Venture Partners, Lilly Asia Ventures, OrbiMed Advisors, and We Capital |
2020-07-29 | Thrive Earlier Detection | Series B | $257M | Bain Capital, Biomatics Capital Partners, Brown Advisory, Casdin Capital, Cowin Venture, Driehaus Capital Management, Exact Sciences, Gamma 3, Intermountain Ventures, Invus Group, Janus Henderson Investors, Lux Capital, Moore Strategic Ventures, Perceptive Advisors, Rock Springs Capital, Sands Capital Ventures, Section 32, T. Rowe Price, The Blue Venture Fund, and Third Rock Ventures |
2020-06-24 | Catalio Capital Management | Spinoff / Spinout |